drugset / Trial / NCT02983708
Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells
Phase 1/2
Completed
57 enrolled
Hanyang University Seoul Hospital
Ministry of Health & Welfare, Korea · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The current study describes a randomized, double-blind, cross-over study of intravenous G-CSF followed by infusion with autologous mobilized peripheral blood mononuclear cells (mPBMCs) in children with cerebral palsy (CP) to determine the safety and feasibility of the procedure, as well as the potential efficacy for improving neurological impairment.
Timeline
- Start
- 2011-08
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Granulocyte colony-stimulating factor | Protein / enzyme biologic | — | Intravenous |
| Subject | Peripheral blood mononuclear cells | Cell therapy | — | Other |